Early tumor shrinkage (ETS) as clinical factor to select maintenance with cetuximab (cet) monotherapy in patients (pts) with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): A secondary endpoint analysis of the ERMES study

被引：0

作者：

Orlandi, Armando

Pinto, Carmine

Calegari, Maria Alessandra

Normanno, Nicola

Maiello, Evaristo

Antonuzzo, Lorenzo

Bordonaro, Roberto

Zampino, M. Giulia

Bergamo, Francesca

Tonini, Giuseppe

Tamberi, Stefano

Avallone, Antonio

Latiano, Tiziana Pia

Rosati, Gerardo

Pazzola, Antonio

Ballestrero, Alberto

Zaniboni, Alberto

Formica, Vincenzo

Barone, Carlo

机构：

[1] Fdn Policlini Univ A Gemelli IRCCS, UOC Oncol Med, Rome, Italy

[2] Azienda USL IRCCS Reggio Emilia, Med Oncol Unit, Reggio Emilia, Italy

[3] Fdn Policlin Univ Agostino Gemelli, Med Oncol Unit, IRCCS, Rome, Italy

[4] G Pascale Foudat, Natl Canc Inst Naples, Brusciano, Italy

[5] Fdn IRCSS Casa Sollievo Sofferenza, Oncol Unit, San Giovanni Rotondo, Italy

[6] Careggi Univ Hosp, Clin Oncol Unit, Dept Expt & Clin Med, Florence, Italy

[7] Azienda Osped ARNAS Garibaldi, Med Oncol, Catania, CT, Italy

[8] Ist Europeo Oncol, Milan, Italy

[9] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Med Oncol 1, Padua, Italy

[10] Univ Campus Biomed, Dept Med Oncol, Rome, Italy

[11] Oncol Unit, Osped Santa Maria Croci, Ravenna, Italy

[12] Fondazione G Pascale Napoli, Ist Nazl Tumori, Naples, Italy

[13] Fdn IRCCS Casa Sollievo Sofferenza, Oncol Unit, San Giovanni Rotondo, Italy

[14] Azienda Osped S Carlo, Potenza, Italy

[15] Osped Civili SS Annunziata, Dept Med Oncol, Sassari, Italy

[16] Univ Genoa, Genoa, Italy

[17] CdC Poliambulanza, Brescia, Italy

[18] Univ Rome, Med Oncol Unit, Tor Vergata Clin Ctr, Rome, RM, Italy

[19] Fdn Policlin Univ A Gemelli IRCCS Roma, Rome, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3603

引用

页数：1

共 50 条

[21] Early tumour shrinkage (ETS) and its impact on tumour-related symptoms in patients with previously untreated RAS wild-type (WT) metastatic colorectal cancer (mCRC): a retrospective analysis of three panitumumab (pmab) studies
Geissler, M.
Taieb, J.
Rivera, F.
Karthaus, M.
Wilson, R.
Loupakis, F.
Price, T.
Tracy, M.
Burdon, P.
Peeters, M.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 120 - 122
[22] Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer
Manca, Paolo
Corallo, Salvatore
Randon, Giovanni
Lonardi, Sara
Cremolini, Chiara
Rimassa, Lorenza
Bergamo, Francesca
Antoniotti, Carlotta
Smiroldo, Valeria
Zaniboni, Alberto
Murialdo, Roberto
Tampellini, Marco
Tomasello, Gianluca
Clavarezza, Matteo
Racca, Patrizia
Antista, Maria
Raimondi, Alessandra
Prisciandaro, Michele
Pagani, Filippo
Palermo, Federica
Greco, Francesca Gabriella
Vaiani, Marta
Di Bartolomeo, Maria
de Braud, Filippo
Calareso, Giuseppina
Morano, Federica
Pietrantonio, Filippo
EUROPEAN JOURNAL OF CANCER, 2021, 144 : 31 - 40
[23] Early tumour shrinkage (ETS), depth of response (DpR) and associated survival outcomes in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC) classified according to Kohne prognostic category: Retrospective analysis of the panitumumab (Pmab) PRIME study
Sartore-Bianchi, A.
Peeters, M.
Geissler, M.
Taieb, J.
Garcia-Alfonso, P.
Price, T.
Burdon, P.
Zhang, Y.
Koehne, C-H.
ANNALS OF ONCOLOGY, 2019, 30 : 216 - 216
[24] Final overall survival (OS) analysis of first-line (1L) FOLFOX-4 ± cetuximab (cet) in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase 3 TAILOR trial.
Qin, Shukui
Guo, Weijian
Xu, Jian-Ming
Li, Qi
Cheng, Ying
Liu, Tian Shu
Chen, Jiongjie
Chen, Wen-Feng
Li, Jin
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[25] Importance of tumour symptoms and extent of disease on efficacy of first-line FOLFOX4 ± panitumumab (pmab) in patients (pts) with RAS wild-type (WT)/BRAF WT metastatic colorectal cancer (mCRC) in the PRIME study
Taieb, J.
Peeters, M.
Siena, S.
Rivera Herrero, F.
Koukakis, R.
Demonty, G.
Douillard, J-Y.
ANNALS OF ONCOLOGY, 2016, 27
[26] Impact of primary tumor location (TL) on outcomes of first-line (1L) FOLFOX-4 (F) ± cetuximab (cet) in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase 3 TAILOR trial
Qin, Shukui
Xu, Jian-Ming
Wang, Liwei
Cheng, Ying
Liu, Tian Shu
Chen, Jiongjie
Chen, Wen-Feng
Li, Jin
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[27] Maintenance treatment with capecitabine plus cetuximab (CET) for patients with RAS wild-type (wt) advanced colorectal cancer (CRC): A multi-center, phase II clinical trial.
Yuan, Xianglin
Liu, Ying
Yin, Xianli
Xiong, Jianping
Zhao, Ben
Qiu, Hong
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[28] Randomized intermittent or continuous panitumumab plus FOLFIRI (FOLFIRI/PANI) for first-line treatment of patients (pts) with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): The IMPROVE study.
Avallone, Antonio
Giuliani, Francesco
Nasti, Guglielmo
Montesarchio, Vincenzo
Santabarbara, Giuseppe
Leo, Silvana
De Stefano, Alfonso
Rosati, Gerardo
Lolli, Ivan
Tamburini, Emiliano
Colombo, Alfredo
Santini, Daniele
Silvestro, Lucrezia
Facchini, Gaetano
Mannavola, Francesco
Febbraro, Antonio
Troncone, Giancarlo
Sobrero, Alberto F.
Giannarelli, Diana
Budillon, Alfredo
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[29] Predictive value of primary tumor location (TL) in patients (pts) with pan-RAS wild-type (wt) metastatic colorectal cancer (mCRC) receiving chemotherapy (CTX) ± cetuximab or panitumumab (C/P): An updated meta-analysis.
Wang, Zi-xian
He, Ming-ming
Wang, Ying-Nan
Wang, Feng
Xu, Rui-hua
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
[30] An exploratory analysis evaluating the effect of sequence of biologic therapies on overall survival (OS) in patients (pts) with RAS wild-type (WT) metastatic colorectal carcinoma (mCRC)
Karthaus, M.
Sobrero, A.
Douillard, J. -Y
Rivera, F.
Forget, F.
Valladares-Ayerbes, M.
Demonty, G.
Guan, X.
Peeters, M.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 94 - 94

← 1 2 3 4 5 →